Tolar, Jakub <br/><br/>
Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Jul 2012 
 - 1007-11 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2012.04.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Anemia, Aplastic--mortality<br/>Antilymphocyte Serum--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Bone Marrow Transplantation<br/>Child<br/>Cyclophosphamide--administration & dosage<br/>Drug Administration Schedule<br/>Drug Dosage Calculations<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Survival Rate<br/>Transplantation Conditioning<br/>Unrelated Donors<br/>Vidarabine--administration & dosage<br/>Whole-Body Irradiation--adverse effects